Alzheimer disease 1999: A status report

被引:17
作者
Kowall, NW
机构
[1] Edith Nourse Rogers Mem Vet Adm Hosp, Ctr Geriatr Res Educ & Clin, Bedford, MA 01730 USA
[2] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA
[3] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA
关键词
Alzheimer disease; beta amyloid; antioxidant; antiinflammatory; estrogen; caregiver;
D O I
10.1097/00002093-199904001-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although the cause of Alzheimer disease (AD) remains a mystery, a great deal of progress has been made over the past 15 years. A large body of evidence suggests that beta amyloid (A beta) deposition and toxicity are critical steps leading to neuronal death in AD. Evidence is beginning to show that antioxidant and antiinflammatory drugs and estrogen may prevent, delay onset, or slow the progression of AD. Until a cure is found it will be necessary to provide high-quality long-term and palliative care in the community or in specialized treatment centers. The AD patient's caregiver often suffers in silence and research is needed to better understand disease burden to design appropriate interventions for these victims of AD.
引用
收藏
页码:S11 / S16
页数:6
相关论文
共 85 条
  • [1] Height as a marker of childhood development and late-life cognitive function: The Honolulu-Asia Aging Study
    Abbott, RD
    White, LR
    Ross, GW
    Petrovitch, H
    Masaki, KH
    Snowdon, DA
    Curb, JD
    [J]. PEDIATRICS, 1998, 102 (03) : 602 - 609
  • [2] *AMA COUNC SCI AFF, 1998, JMAA, V91, P298
  • [3] Is apoptosis key in Alzheimer's disease?
    Barinaga, M
    [J]. SCIENCE, 1998, 281 (5381) : 1303 - 1304
  • [4] Mitochondrial Dysfunction in Neurodegenerative Diseases
    Johri, Ashu
    Beal, M. Flint
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (03) : 619 - 630
  • [5] Alpha-2 macroglobulin is genetically associated with Alzheimer disease
    Blacker, D
    Wilcox, MA
    Laird, NM
    Rodes, L
    Horvath, SM
    Go, RCP
    Perry, R
    Watson, B
    Bassett, SS
    McInnis, MG
    Albert, MS
    Hyman, BT
    Tanzi, RE
    [J]. NATURE GENETICS, 1998, 19 (04) : 357 - 360
  • [6] Age-associated memory impairment and Alzheimer's disease
    Blass, JP
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (02) : 209 - 211
  • [7] Blennow K, 1998, J NEURAL TRANSM-SUPP, P223
  • [8] Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease
    Bobinski, M
    de Leon, MJ
    Tarnawski, M
    Wegiel, J
    Bobinski, M
    Reisberg, B
    Miller, DC
    Wisniewski, HM
    [J]. BRAIN RESEARCH, 1998, 805 (1-2) : 267 - 269
  • [9] Factors affecting the age of onset and rate of progression of Alzheimer's disease
    Bowler, JV
    Munoz, DG
    Merskey, H
    Hachinski, V
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (02) : 184 - 190
  • [10] Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide
    Bradt, BM
    Kolb, WP
    Cooper, NR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (03) : 431 - 438